ZA200707142B - Quinolinone compounds as 5-HT4 receptor agonists - Google Patents
Quinolinone compounds as 5-HT4 receptor agonistsInfo
- Publication number
- ZA200707142B ZA200707142B ZA200707142A ZA200707142A ZA200707142B ZA 200707142 B ZA200707142 B ZA 200707142B ZA 200707142 A ZA200707142 A ZA 200707142A ZA 200707142 A ZA200707142 A ZA 200707142A ZA 200707142 B ZA200707142 B ZA 200707142B
- Authority
- ZA
- South Africa
- Prior art keywords
- receptor agonists
- quinolinone compounds
- quinolinone
- compounds
- agonists
- Prior art date
Links
- 108091005482 5-HT4 receptors Proteins 0.000 title 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65800705P | 2005-03-02 | 2005-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200707142B true ZA200707142B (en) | 2008-10-29 |
Family
ID=36588769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200707142A ZA200707142B (en) | 2005-03-02 | 2007-08-23 | Quinolinone compounds as 5-HT4 receptor agonists |
Country Status (16)
Country | Link |
---|---|
US (2) | US7446114B2 (es) |
EP (1) | EP1871772B1 (es) |
JP (1) | JP5042043B2 (es) |
KR (1) | KR20070107807A (es) |
CN (1) | CN101163701A (es) |
AU (1) | AU2006218603A1 (es) |
BR (1) | BRPI0608392A2 (es) |
CA (1) | CA2599404A1 (es) |
EA (1) | EA013567B1 (es) |
ES (1) | ES2523851T3 (es) |
IL (1) | IL185407A0 (es) |
MX (1) | MX2007010769A (es) |
NO (1) | NO20074884L (es) |
NZ (1) | NZ560828A (es) |
WO (1) | WO2006094063A1 (es) |
ZA (1) | ZA200707142B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
TWI377206B (en) | 2005-04-06 | 2012-11-21 | Theravance Inc | Crystalline form of a quinolinone-carboxamide compound |
MY143574A (en) * | 2005-11-22 | 2011-05-31 | Theravance Inc | Carbamate compounds as 5-ht4 receptor agonists |
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
JP5265513B2 (ja) * | 2007-02-19 | 2013-08-14 | 株式会社カネカ | 光学活性3−アミノピペリジン又はその塩の製造方法 |
SG178557A1 (en) * | 2009-09-14 | 2012-03-29 | Suven Life Sciences Ltd | L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands |
TW201642856A (zh) * | 2015-04-02 | 2016-12-16 | 施萬生物製藥研發Ip有限責任公司 | Mu類鴉片受體拮抗劑與類鴉片藥劑之組合劑型 |
WO2023135508A1 (en) | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | PYRROLO[1,2-b]-2-PYRIDAZINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321378A (en) * | 1979-01-16 | 1982-03-23 | Delalande S.A. | 8-(5-Pyrimidinecarboxamide)nor-tropane derivatives |
US4937247A (en) * | 1985-04-27 | 1990-06-26 | Beecham Group P.L.C. | 1-acyl indazoles |
GB8527052D0 (en) * | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
DE3777805D1 (de) * | 1986-11-21 | 1992-04-30 | Glaxo Group Ltd | Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes. |
GB8701022D0 (en) * | 1987-01-19 | 1987-02-18 | Beecham Group Plc | Treatment |
US5223511A (en) * | 1987-09-23 | 1993-06-29 | Boehringer Ingelheim Italia S.P.A. | Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists |
IT1231413B (it) | 1987-09-23 | 1991-12-04 | Angeli Inst Spa | Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht |
IT1226389B (it) * | 1988-07-12 | 1991-01-15 | Angeli Inst Spa | Nuovi derivati ammidinici e guanidinici |
NZ230068A (en) * | 1988-07-29 | 1991-07-26 | Dainippon Pharmaceutical Co | Indazole-3-carboxylic acid esters and amides of diaza compounds having 6,7, or 8 ring members: preparatory processes and pharmaceutical compositions |
EP0410509A1 (en) * | 1989-07-25 | 1991-01-30 | Duphar International Research B.V | New substituted 1H-indazole-3-carboxamides |
JPH045289A (ja) | 1990-04-24 | 1992-01-09 | Hokuriku Seiyaku Co Ltd | アミド化合物 |
JP3122671B2 (ja) * | 1990-05-23 | 2001-01-09 | 協和醗酵工業株式会社 | 複素環式化合物 |
HU211081B (en) * | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
DE69113284T2 (de) * | 1990-12-28 | 1996-02-22 | Kyowa Hakko Kogyo Co., Ltd., Tokio/Tokyo | Chinolinderivat. |
AU2435092A (en) | 1991-08-20 | 1993-03-16 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
US5552398A (en) * | 1991-09-12 | 1996-09-03 | Smithkline Beecham P.L.C. | Azabicyclic compounds as 5-HT4 receptor antagonists |
MX9305947A (es) * | 1992-09-29 | 1994-06-30 | Smithkline Beecham Plc | Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. |
AU5161593A (en) * | 1992-11-20 | 1994-06-22 | Taisho Pharmaceutical Co., Ltd. | Heterocyclic compound |
TW251287B (es) | 1993-04-30 | 1995-07-11 | Nissei Co Ltd | |
GB9310582D0 (en) * | 1993-05-22 | 1993-07-07 | Smithkline Beecham Plc | Pharmaceuticals |
WO1995023147A1 (fr) * | 1994-02-28 | 1995-08-31 | Taisho Pharmaceutical Co., Ltd. | Compose heterocyclique |
US5864039A (en) * | 1994-03-30 | 1999-01-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and use thereof as medicaments |
GB9406857D0 (en) * | 1994-04-07 | 1994-06-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
JP3829879B2 (ja) * | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | キノリンカルボン酸誘導体 |
US5684003A (en) * | 1994-10-20 | 1997-11-04 | Nisshin Flour Milling Co., Ltd. | 5-HT4 receptor agonists |
JP3829880B2 (ja) | 1994-12-27 | 2006-10-04 | 大正製薬株式会社 | 化学中間体 |
IT1275903B1 (it) * | 1995-03-14 | 1997-10-24 | Boehringer Ingelheim Italia | Esteri e ammidi della 1,4-piperidina disostituita |
US5654320A (en) * | 1995-03-16 | 1997-08-05 | Eli Lilly And Company | Indazolecarboxamides |
KR19990022096A (ko) * | 1995-05-31 | 1999-03-25 | 쇼다 오사무 | 모노시클릭 아미노기를 갖는 인다졸 유도체 |
ES2109190B1 (es) | 1996-03-22 | 1998-07-01 | Univ Madrid Complutense | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
IT1291569B1 (it) * | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
TW402591B (en) * | 1997-07-11 | 2000-08-21 | Janssen Pharmaceutica Nv | Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
US5914405A (en) * | 1997-10-07 | 1999-06-22 | Eli Lilly And Company | Process for preparing 3-substituted indazoles |
US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
FR2769915B1 (fr) | 1997-10-21 | 2000-10-13 | Synthelabo | Derives d'indazole tricycliques, leur preparation et leur application en therapeutique |
IT1298271B1 (it) | 1998-02-18 | 1999-12-20 | Boehringer Ingelheim Italia | Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico |
KR20010043032A (ko) * | 1998-04-28 | 2001-05-25 | 도모따께 다께시 | 1-[(1-치환-4-피페리디닐)메틸]-4-피페리딘 유도체, 그의제조방법, 그것을 함유하는의약조성물 및 이 화합물의중간체 |
AU758807B2 (en) * | 1998-09-10 | 2003-03-27 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxine carboxamide and ketone derivatives as 5-HT4 receptor antagonists |
TW570920B (en) * | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
FR2792318B1 (fr) | 1999-04-16 | 2001-06-15 | Synthelabo | Derives d'indazole, leur preparation et leur application en therapeutique |
AU5259100A (en) * | 1999-04-28 | 2000-11-10 | Respiratorius Ab | Medicament |
ES2154605B1 (es) | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
IT1313625B1 (it) * | 1999-09-22 | 2002-09-09 | Boehringer Ingelheim Italia | Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina. |
IT1313660B1 (it) | 1999-10-01 | 2002-09-09 | Dompe Spa | Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani. |
WO2002036113A1 (en) | 2000-11-01 | 2002-05-10 | Respiratorius Ab | Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4) |
US6624162B2 (en) * | 2001-10-22 | 2003-09-23 | Pfizer Inc. | Imidazopyridine compounds as 5-HT4 receptor modulators |
US20030100426A1 (en) * | 2001-11-28 | 2003-05-29 | Jerry Lin | Method for producing semi-transparent lamp shades from the unsaturated resin |
MXPA03000145A (es) * | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
US6696468B2 (en) * | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
DOP2003000703A (es) * | 2002-09-20 | 2004-03-31 | Pfizer | Compuestos de imidazopiradina como agonistas del receptor 5-ht4 |
EP1543004A1 (en) * | 2002-09-20 | 2005-06-22 | Pfizer Inc. | N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators |
CA2523077A1 (en) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity |
JO2478B1 (en) | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
EA009259B1 (ru) | 2003-06-19 | 2007-12-28 | Янссен Фармацевтика Н.В. | Аминосульфонилзамещенные 4-(аминометил)пиперидинбензамиды в качестве 5ht-антагонистов |
KR100738784B1 (ko) | 2003-09-03 | 2007-07-12 | 화이자 인코포레이티드 | 5-ht4 수용체 효능 활성을 갖는 벤즈이미다졸론 |
US7346224B2 (en) * | 2003-11-07 | 2008-03-18 | Mitsubishi Electric Research Laboratories, Inc. | System and method for classifying pixels in images |
CA2545092C (en) | 2003-11-24 | 2010-08-17 | Pfizer Inc. | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
US7691881B2 (en) | 2004-01-29 | 2010-04-06 | Pfizer Inc | 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-HT4 receptor agonistic activity |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
WO2005092882A1 (en) | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
MXPA06014486A (es) * | 2004-06-15 | 2007-03-01 | Pfizer | Derivados de acido carboxilico de bencimidazolona. |
US7737163B2 (en) * | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
ES2327142T3 (es) | 2004-11-05 | 2009-10-26 | Theravance, Inc. | Compuestos de quinolinona-carboxamida. |
WO2006052640A1 (en) | 2004-11-05 | 2006-05-18 | Theravance, Inc. | 5-ht4 receptor agonist compounds |
NZ555180A (en) | 2004-12-22 | 2010-09-30 | Theravance Inc | Indazole-carboxamide compounds useful as 5-HT4 receptor agonists |
ATE495171T1 (de) | 2005-06-07 | 2011-01-15 | Theravance Inc | Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors |
MY143574A (en) | 2005-11-22 | 2011-05-31 | Theravance Inc | Carbamate compounds as 5-ht4 receptor agonists |
-
2006
- 2006-03-01 NZ NZ560828A patent/NZ560828A/en not_active IP Right Cessation
- 2006-03-01 KR KR1020077022429A patent/KR20070107807A/ko not_active Application Discontinuation
- 2006-03-01 WO PCT/US2006/007284 patent/WO2006094063A1/en active Application Filing
- 2006-03-01 JP JP2007558181A patent/JP5042043B2/ja not_active Expired - Fee Related
- 2006-03-01 EP EP06736578.3A patent/EP1871772B1/en active Active
- 2006-03-01 CA CA002599404A patent/CA2599404A1/en not_active Abandoned
- 2006-03-01 US US11/365,320 patent/US7446114B2/en active Active
- 2006-03-01 MX MX2007010769A patent/MX2007010769A/es active IP Right Grant
- 2006-03-01 EA EA200701867A patent/EA013567B1/ru not_active IP Right Cessation
- 2006-03-01 AU AU2006218603A patent/AU2006218603A1/en not_active Abandoned
- 2006-03-01 CN CNA2006800131887A patent/CN101163701A/zh active Pending
- 2006-03-01 ES ES06736578.3T patent/ES2523851T3/es active Active
- 2006-03-01 BR BRPI0608392-7A patent/BRPI0608392A2/pt not_active IP Right Cessation
-
2007
- 2007-08-21 IL IL185407A patent/IL185407A0/en unknown
- 2007-08-23 ZA ZA200707142A patent/ZA200707142B/xx unknown
- 2007-09-25 NO NO20074884A patent/NO20074884L/no not_active Application Discontinuation
-
2008
- 2008-09-22 US US12/234,906 patent/US7875629B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO20074884L (no) | 2007-11-29 |
US7875629B2 (en) | 2011-01-25 |
AU2006218603A1 (en) | 2006-09-08 |
ES2523851T3 (es) | 2014-12-02 |
BRPI0608392A2 (pt) | 2009-12-29 |
IL185407A0 (en) | 2008-01-06 |
MX2007010769A (es) | 2008-03-07 |
JP2008531711A (ja) | 2008-08-14 |
WO2006094063A1 (en) | 2006-09-08 |
JP5042043B2 (ja) | 2012-10-03 |
CA2599404A1 (en) | 2006-09-08 |
NZ560828A (en) | 2011-01-28 |
US20060199839A1 (en) | 2006-09-07 |
EP1871772B1 (en) | 2014-09-10 |
US20090036483A1 (en) | 2009-02-05 |
EA200701867A1 (ru) | 2008-02-28 |
CN101163701A (zh) | 2008-04-16 |
EP1871772A1 (en) | 2008-01-02 |
KR20070107807A (ko) | 2007-11-07 |
US7446114B2 (en) | 2008-11-04 |
EA013567B1 (ru) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1099019A1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
IL177059A0 (en) | Indazole-carboxamide compounds as 5-ht4 receptor agonists | |
HK1135966A1 (en) | Oxyindole derivatives as 5ht4 receptor agonists | |
IL186883A0 (en) | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists | |
IL188550A0 (en) | Heterocyclic compounds as agonists for the thyroid receptor | |
IL186150A0 (en) | Novel thiophene derivatives as sphingosine-1-1phosphate-1 receptor agonists | |
HK1140761A1 (en) | Indole derivatives as s1p1 receptor agonists | |
ZA200709086B (en) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
EP2079466A4 (en) | SUBSTITUTED INDOLE COMPOUNDS | |
ZA200800320B (en) | Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists | |
HK1124233A1 (en) | Quinoline derivatives as antibacterical agents | |
ATE549350T1 (de) | Neuropeptid-2-rezeptor-agonisten | |
ZA200707142B (en) | Quinolinone compounds as 5-HT4 receptor agonists | |
IL192308A0 (en) | Oxazoloisoquinoline derivatives as thrombin receptor antagonists | |
IL198542A0 (en) | 2-aminoquinolines as 5-ht(5a)receptor antagonists | |
ZA200900843B (en) | Indole compounds | |
ZA200903499B (en) | Indoles which act as via receptor antagonists | |
ZA200903829B (en) | Indole derivatives as S1P1 receptor agonists | |
ZA200804010B (en) | Carbamate compounds as 5-HT4 receptor agonists | |
GB0519969D0 (en) | Quinoline compounds | |
GB0525029D0 (en) | Receptor Antagonist | |
ZA200709829B (en) | Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists | |
GB0516439D0 (en) | EP2 receptor agonists | |
GB0614580D0 (en) | Agonists 1A |